British Biotech offers £48m for Vernalis
The UK biotechnology industry is gearing up for yet another bout of consolidation with the news that British Biotech has made a £48 million (€73m) offer for Vernalis.
The UK biotechnology industry is gearing up for yet another bout of consolidation with the news that British Biotech has made a £48 million (€73m) offer for Vernalis.
Finland's Jurilab has developed a new microarray product designed for use in DME (drug metabolism enzyme) testing, and also signed up its first customer for the technology.